address1,address2,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,regularMarketChangePercent,regularMarketPrice,corporateActions,regularMarketTime,exchange,market,shortName,longName,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,trailingPegRatio
Novum,Floor 8 Hälsovägen 7 elevator E,Huddinge,141 57,Sweden,46 84 11 44 55,https://www.sprintbioscience.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden.",38,"[{'maxAge': 1, 'name': 'Mr. Johan  Emilsson', 'age': 40, 'title': 'Chief Executive Officer', 'yearBorn': 1984, 'fiscalYear': 2024, 'totalPay': 2224000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Pär  Nordlund', 'age': 66, 'title': 'Founder', 'yearBorn': 1958, 'fiscalYear': 2024, 'totalPay': 25000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Martin  Andersson', 'age': 53, 'title': 'Co-Founder, Research Director & Chief Scientific Officer', 'yearBorn': 1971, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kenth  Hallberg', 'age': 53, 'title': 'Founder & Director of Structural Chemistry', 'yearBorn': 1971, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Niklas  Axelsson', 'age': 51, 'title': 'Chief Financial Officer', 'yearBorn': 1973, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Anne-Marie  Wenthzel', 'age': 60, 'title': 'Chief Business Officer', 'yearBorn': 1964, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,4,0.504,0.54,0.48,0.54,0.504,0.54,0.48,0.54,0.0,-0.567,0.37615386,78002,78002,217256,132472,132472,0.488,0.496,0,0,34717676,0.36,2.25,0.55656034,0.4916,1.1915618,0.0,0.0,SEK,False,14589003,-0.33418,40254075,70997296,0.28542,0.17712,70997296,0.052,9.403846,1735603200,1767139200,1743379200,-20846000,-0.3,1.3,0.234,-0.769,-0.6238806,0.12792087,EQUITY,0.489,2.0,2.0,2.0,2.0,0.0,strong_buy,1,18785000,0.269,-18971000,0,0.969,0.969,62379000,0.893,-0.28932,-1.47155,36097000,-13021875,-19591000,-0.211,0.57867,-0.30412,-0.37076,SEK,SPRINT.ST,en-US,US,Equity,Delayed Quote,True,HIGH,PREPRE,finmb_113333582,Europe/Stockholm,CEST,7200000,False,-2.9761934,0.489,[],1751553852,STO,se_market,Sprint Bioscience AB,Sprint Bioscience AB (publ),False,1415347200000,-0.0150000155,0.48 - 0.54,Stockholm,217256,0.12899998,0.35833326,0.36 - 2.25,-1.761,-0.7826667,-62.38806,1756292340,1756292340,1756292340,False,-0.3,1.3,0.1,4.89,-0.0026000142,-0.0052888817,-0.70256186,-0.5896143,15,0,0.0 - Strong Buy,False,
